Lv31
229 积分 2026-06-10 加入
The Association of Proteinuria Target Achievement Timing and Stability with Adverse Kidney Outcomes among Patients with IgA Nephropathy: A Cohort Study
1个月前
已完结
The role of innate lymphoid cells in kidney disease
1个月前
已完结
Clinical remission trajectories and histopathological associations in patients with IgA nephropathy treated with targeted-release budesonide: a real-world cohort study
1个月前
已完结
Clinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease
2个月前
已完结
In IgA nephropathy, oral methylprednisolone reduced adverse kidney outcomes but increased adverse events
3个月前
已完结
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
3个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
